Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse
Background Adaptive CD19-targeted chimeric antigen receptor (CAR) T-cell transfer has become a promising treatment for leukemia. Although patient responses vary across different clinical trials, reliable methods to dissect and predict patient responses to novel therapies are currently lacking. Recen...
Saved in:
| Main Authors: | Chao Ma, Weiqiang Chen, Lunan Liu, Zhuoyu Zhang, Matthew T Witkowski, Iannis Aifantis, Saba Ghassemi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/12/e005360.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
by: Lauren Elreda, et al.
Published: (2014-01-01) -
Complete Remission with Inotuzumab Ozogamicin as Fourth-Line Salvage Therapy in a Child with Relapsed/Refractory Acute Lymphoblastic Leukemia
by: Athanasios Tragiannidis, et al.
Published: (2024-09-01) -
Evaluation of Inflammation-Related Proteins in Multiple Sclerosis Disease with Relapses and Remissions
by: Nisa Hocaoğlu, et al.
Published: (2024-08-01) -
Remission of Severe, Relapsed, and Refractory TTP after Multiple Cycles of Bortezomib
by: Manu R. Pandey, et al.
Published: (2017-01-01) -
Platelet Indices as Quility markers For Remission in patients with Leukemia
by: Suleimman Al-Sweedan, et al.
Published: (2014-08-01)